Cargando…

Targeting Neuroblastoma Stem Cells with Retinoic Acid and Proteasome Inhibitor

BACKGROUND: Neuroblastma cell lines contain a side-population of cells which express stemness markers. These stem-like cells may represent the potential underlying mechanism for resistance to conventional therapy and recurrence of neuroblastoma in patients. METHODOLOGY/PRINCIPAL FINDINGS: To develop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hämmerle, Barbara, Yañez, Yania, Palanca, Sarai, Cañete, Adela, Burks, Deborah J., Castel, Victoria, Font de Mora, Jaime
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792090/ https://www.ncbi.nlm.nih.gov/pubmed/24116151 http://dx.doi.org/10.1371/journal.pone.0076761

Ejemplares similares

TIAM1 variants improve clinical outcome in neuroblastoma
por: Sanmartín, Elena, et al.
Publicado: (2017)

Clinical Features of Neuroblastoma With 11q Deletion: An Increase in Relapse Probabilities In Localized And 4S Stages
por: J Ribelles, Antonio, et al.
Publicado: (2019)

Two independent epigenetic biomarkers predict survival in neuroblastoma
por: Yáñez, Yania, et al.
Publicado: (2015)

Publisher Correction: Clinical Features of Neuroblastoma With 11q Deletion: An Increase in Relapse Probabilities In Localized And 4S Stages
por: Juan Ribelles, Antonio, et al.
Publicado: (2020)

Intratumoral immunosuppression profiles in 11q‐deleted neuroblastomas provide new potential therapeutic targets
por: Coronado, Esther, et al.
Publicado: (2021)

MTHFR and VDR Polymorphisms Improve the Prognostic Value of MYCN Status on Overall Survival in Neuroblastoma Patients
por: Olivera, Gladys G., et al.
Publicado: (2020)

Next-Generation Sequencing Identifies Potential Actionable Targets in Paediatric Sarcomas
por: Juan Ribelles, Antonio, et al.
Publicado: (2021)

Pharmacogenetics in Neuroblastoma: What Can Already Be Clinically Implemented and What Is Coming Next?
por: Olivera, Gladys G., et al.
Publicado: (2021)

Evaluation of circulating tumor DNA by electropherogram analysis and methylome profiling in high-risk neuroblastomas
por: Trinidad, Eva María, et al.
Publicado: (2023)

Pharmacogenetics implementation in the clinics: information and guidelines for germline variants
por: Olivera, Gladys, et al.
Publicado: (2019)

Germline Predisposition to Pediatric Cancer, from Next Generation Sequencing to Medical Care
por: Gargallo, Pablo, et al.
Publicado: (2021)

Retinoblastoma and mosaic 13q deletion: a case report
por: Gargallo, Pablo, et al.
Publicado: (2021)

Neuroblastoma after Childhood: Prognostic Relevance of Segmental Chromosome Aberrations, ATRX Protein Status, and Immune Cell Infiltration()
por: Berbegall, Ana P., et al.
Publicado: (2014)

Exosomal microRNAs from Longitudinal Liquid Biopsies for the Prediction of Response to Induction Chemotherapy in High-Risk Neuroblastoma Patients: A Proof of Concept SIOPEN Study (‖)
por: Morini, Martina, et al.
Publicado: (2019)

Liquidhope: methylome and genomic profiling from very limited quantities of plasma-derived DNA
por: Trinidad, Eva María, et al.
Publicado: (2023)

Novel proteasome inhibitor ixazomib sensitizes neuroblastoma cells to doxorubicin treatment
por: Li, Haoyu, et al.
Publicado: (2016)

How to minimise the effect of tumour cell content in detection of aberrant genetic markers in neuroblastoma
por: Piqueras, M, et al.
Publicado: (2011)

Vitronectin as a molecular player of the tumor microenvironment in neuroblastoma
por: Burgos-Panadero, Rebeca, et al.
Publicado: (2019)

Epigenetics and Oxidative Stress in Aging
por: Guillaumet-Adkins, Amy, et al.
Publicado: (2017)

Second-generation proteasome inhibitor carfilzomib sensitizes neuroblastoma cells to doxorubicin-induced apoptosis
por: Guan, Shan, et al.
Publicado: (2016)

Retinoic acid induces differentiation in neuroblastoma via ROR1 by modulating retinoic acid response elements
por: Illendula, Abhinav, et al.
Publicado: (2020)

miR‐200c and phospho‐AKT as prognostic factors and mediators of osteosarcoma progression and lung metastasis
por: Berlanga, Pablo, et al.
Publicado: (2016)

γ-secretase inhibitor I inhibits neuroblastoma cells, with NOTCH and the proteasome among its targets
por: Dorneburg, Carmen, et al.
Publicado: (2016)

ATM depletion induces proteasomal degradation of FANCD2 and sensitizes neuroblastoma cells to PARP inhibitors
por: Parvin, Sultana, et al.
Publicado: (2023)

Molecular targeting of retinoic acid metabolism in neuroblastoma: the role of the CYP26 inhibitor R116010 in vitro and in vivo
por: Armstrong, J L, et al.
Publicado: (2007)

Increasing the intracellular availability of all-trans retinoic acid in neuroblastoma cells
por: Armstrong, J L, et al.
Publicado: (2005)

Retinoic acid-induced CHD5 upregulation and neuronal differentiation of neuroblastoma
por: Higashi, Mayumi, et al.
Publicado: (2015)

Retinoic acid rewires the adrenergic core regulatory circuitry of childhood neuroblastoma
por: Zimmerman, Mark W., et al.
Publicado: (2021)

Store-operated Ca(2 +) entry in proliferating and retinoic acid-differentiated N- and S-type neuroblastoma cells
por: Bell, Natalie, et al.
Publicado: (2013)

Lymph microvascularization as a prognostic indicator in neuroblastoma
por: Tadeo, Irene, et al.
Publicado: (2018)

Alterations in neuroblastoma ganglioside synthesis by induction of GD1b synthase by retinoic acid
por: Hettmer, S, et al.
Publicado: (2004)

Nuclear GRP75 Binds Retinoic Acid Receptors to Promote Neuronal Differentiation of Neuroblastoma
por: Shih, Yu-Yin, et al.
Publicado: (2011)

Effect of retinoic acid and delta-like 1 homologue (DLK1) on differentiation in neuroblastoma
por: Kim, Yuri
Publicado: (2010)

Redox balance influences differentiation status of neuroblastoma in the presence of all-trans retinoic acid
por: Silvis, Anne M., et al.
Publicado: (2015)

Differentiating Neuroblastoma: A Systematic Review of the Retinoic Acid, Its Derivatives, and Synergistic Interactions
por: Bayeva, Nadiya, et al.
Publicado: (2021)

The MYCN inhibitor BGA002 restores the retinoic acid response leading to differentiation or apoptosis by the mTOR block in MYCN-amplified neuroblastoma
por: Lampis, Silvia, et al.
Publicado: (2022)

Role of Vitamin A/Retinoic Acid in Regulation of Embryonic and Adult Hematopoiesis
por: Cañete, Ana, et al.
Publicado: (2017)

Proteasome inhibitors in glioblastoma
por: Huang, Wen-Juan, et al.
Publicado: (2017)

Proteasome inhibitors in glioblastoma
por: Huang, Wen-Juan, et al.
Publicado: (2017)

Identification of Phosphoproteins as Possible Differentiation Markers in All-Trans-Retinoic Acid-Treated Neuroblastoma Cells
por: Mandili, Giorgia, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_glprmk3plbd6oull00s79he48a